RFPATTACHMENT10.pdf

PDF 10 KB Posted

Attached to
FDA-Wide Capital Planning Investment and Control
Solicitation number
FDA-SOL-12-1099989
Issued by

About this file

RFP Attachment No. 10 Commercial Client Authorization Form

View the file

Other files

File Type Posted
RFPATTACHMENT2(2).pdf PDF
RFPATTACHMENT1.pdf PDF
CPICSOLICITATION.pdf PDF
ResponsestoVendorQuestions.pdf PDF
ResponsestoVendorQuestions.pdf PDF
ResponsestoVendorQuestions.pdf PDF
RFPATTACHMENT2(2).pdf PDF
RFPATTACHMENT1.pdf PDF
CPICSOLICITATION.pdf PDF
RFPATTACHMENT5.xlsx XLSX spreadsheet
RFPATTACHMENT4.xlsx XLSX spreadsheet
RFPATTACHMENT9.pdf PDF
RFPATTACHMENT5.xlsx XLSX spreadsheet
SF1449.pdf PDF
RFPATTACHMENT1.pdf PDF
Appendix A.docx DOCX document
RFPATTACHMENT4.xlsx XLSX spreadsheet
RFPATTACHMENT2(2).pdf PDF
AppendixCSOPs.docx DOCX document
RFPATTACHMENT3 —
RFPATTACHMENT6.docx DOCX document
CPICSOLICITATION.pdf PDF
RFPATTACMENT8 .pdf PDF
AppendixESampleMSR.docx DOCX document
RFPATTACHMENT7.pdf PDF
AppendixBInvestmentList.xlsx XLSX spreadsheet
AppendixDScorecard.pdf PDF
Show all 27

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

FDA-SOL-12-1099989 Page 1 of 1

ATTACHMENT 10: COMMERCIAL CLIENT AUTHORIZATION FORM

COMMERCIAL CLIENT AUTHORIZATION FORM

SAMPLE

(For commercial contracts)

Note: This should be placed on company letterhead.

Client Authorization Letter

Dear (Commercial Client/Customer)

We are currently responding to the FDA’S Request for Proposal (RFP No.) for the (program title or description of effort).

The Government is placing increased emphasis on past performance in order to obtain best value in source selections.

They are requesting that clients of companies who submit proposals in response to their RFP for the program/effort identified above be identified and that their participation in the validation process be requested. Therefore, in the event you are contacted for information on work we have performed on (list program), you are hereby authorized to respond to those inquiries.

We have identified Mr./Ms. (Name) of our organization as the point of contact based on their knowledge concerning our work. Your cooperation is appreciated. Any questions may be directed to (Name, title, phone number, and fax number for the PCO).

Sincerely, (Offeror’s point-of-contact)

FDA-SOL-12-1099989 Page 2 of 1

ATTACHMENT 10: COMMERCIAL CLIENT AUTHORIZATION FORM

File details come from the government source that posted it. Updated .